Use of Empagliflozin in Patients with Hypertrophic Cardiomyopathy
EMPA REPAIR HCM
Hypertrophic cardiomyopathy (HCM) is the most common genetically conditioned disease of the heart muscle. Classically, the frequency of this disease was estimated
Support Center
at the National Institute of Cardiology operating in a shared services model,
providing support for commercial and non-commercial clinical trials.
operating in a shared services model, which, thanks to a new approach to conducting clinical trials,
will contribute to the elimination of existing barriers in our system.
clinical research projects, both commercial and non-commercial,
with a total value exceeding 30,000,000 PLN!
Acquiring Sponsors and Partners
Procurement of Clinical Trials
Coordination of Clinical Trials
Ensuring Patient Safety
Network of Specialized Clinical Trial Support Centers
Better coordination of clinical trials in Poland
The National Institute of Cardiology is one of ten highly specialized Clinical Trial Support Centers, forming a network of centers creating a new, common Polish brand.
I believe that the network’s activities will contribute to increasing the availability, quality, and safety of clinical trials conducted in Poland, both commercial and non-commercial.
The actions undertaken will create a new quality in the clinical trial market, which will increase the chances for patients to access modern, innovative therapies.
- Quality
- Availability
- Safety
We are here for you
Get to know our Center
Previous
Next
Transparent and fair cooperation principles.
Do you want to sponsor a clinical trial?
Transparent principles
Common goals and benefits
Network of experts and specialists
Form for sponsors
Leave your details
To establish cooperation, leave your details using this form, providing your contact information and a description of the matter.
To contact us, you can also use the information provided on the contact page.
The true measure of success is what we can boast about!
Discover our projects
We have currently launched, or are in the process of launching clinical trial projects, both commercial and non-commercial, with a total value exceeding PLN 30,000,000!
- Over 3000 patients planned for inclusion
- Nearly 50 recruiting centers nationwide
- 7 highly qualified Research Teams
- 5 specialized Project Teams
Optimal pharmacotherapy in patients undergoing structural procedures within the left atrium with access through the interatrial septum in the perioperative perspective
STOP CLOT, SAFE LAAC I SAFE LAAC CKD
With the aging of the Polish population, the demand for cardiological endovascular structural procedures with documented value
Multicenter Polish Study on the Use of Bromocriptine in Peripartum Cardiomyopathy
PolBroM-PPCM
Peripartum cardiomyopathy (PPCM) is a life-threatening disease with reduced left ventricular ejection fraction (LVEF) <45%, occurring at the end of pregnancy or in the
News
Stay up to date with news from our website.
The National Institute of Cardiology Among the Winners of the ABM Contest to Establish a Clinical Research Support Center
The Stefan Cardinal Wyszyński National Institute of Cardiology – a State Research Institute, has been listed among the ten laureates of the contest announced by
The National Institute of Cardiology has received funding from the Medical Research Agency
The National Institute of Cardiology has received funding from the Medical Research Agency for a project titled “Application of empagliflozin in patients with hypertrophic cardiomyopathy”.
Another project of the National Institute of Cardiology has received funding from the Medical Research Agency
The National Institute of Cardiology has received additional support from the Medical Research Agency to implement a project for non-commercial clinical trials. Two non-commercial clinical